000 | 01977 a2200601 4500 | ||
---|---|---|---|
005 | 20250514015125.0 | ||
264 | 0 | _c20011207 | |
008 | 200112s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI12745 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aQuattropani, C | |
245 | 0 | 0 |
_aReduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cNov 2001 |
||
300 |
_a1299-305 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a11-beta-Hydroxysteroid Dehydrogenase Type 2 |
650 | 0 | 4 | _a11-beta-Hydroxysteroid Dehydrogenases |
650 | 0 | 4 | _aActive Transport, Cell Nucleus |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAldosterone _xblood |
650 | 0 | 4 |
_aBile Acids and Salts _xblood |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aChenodeoxycholic Acid _xblood |
650 | 0 | 4 |
_aCholestasis _xenzymology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrosis _xmetabolism |
650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocortisone _xmetabolism |
650 | 0 | 4 |
_aHydroxysteroid Dehydrogenases _xmetabolism |
650 | 0 | 4 |
_aKidney _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aModels, Chemical |
650 | 0 | 4 |
_aPotassium _xmetabolism |
650 | 0 | 4 |
_aSodium _xmetabolism |
650 | 0 | 4 |
_aTetrahydrocortisol _xchemistry |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aVogt, B | |
700 | 1 | _aOdermatt, A | |
700 | 1 | _aDick, B | |
700 | 1 | _aFrey, B M | |
700 | 1 | _aFrey, F J | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 108 _gno. 9 _gp. 1299-305 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI12745 _zAvailable from publisher's website |
999 |
_c11612074 _d11612074 |